Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia—Major Patients with the XmnI Polymorphism-Reference-Cited by-同舟云学术

Drug Repurposing: Hydroxyurea Therapy Improves the Transfusion-Free Interval in HbE/Beta-Thalassemia—Major Patients with the XmnI Polymorphism

Author:

Ghosh Debojoyti¹²,Panja Amrita²^ORCID,Saha Dipankar²,Banerjee Uma¹,Datta Asok Kumar³,Basu Anupam²^ORCID

Affiliation:

1. Department of Pathology, Burdwan Medical College and Hospital, Burdwan, India.

2. Molecular Biology and Human Genetics Laboratory, Department of Zoology, The University of Burdwan, Burdwan, India.

3. Department of Paediatric Medicine, Burdwan Medical College and Hospital, Burdwan, India.

Publisher

Mary Ann Liebert Inc

Subject

Genetics(clinical),General Medicine

Link

Reference30 articles.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Thalassaemia—A global view;British Journal of Haematology;2023-02-17

5. Thalassemias: from gene to therapy;Molecular Aspects of Medicine;2022-04